Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection

SARS-CoV-2 remains a global health crisis even with effective vaccines and the availability of FDA approved therapies. Efforts to understand the complex disease pathology and develop effective strategies to limit mortality and morbidity are needed. Recent studies reveal circulating Galectin-9 (gal-9...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Stephen T., Premeaux, Thomas A., Du, Li, Niki, Toshiro, Pillai, Satish K., Khanna, Kamal M., Ndhlovu, Lishomwa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621319/
https://www.ncbi.nlm.nih.gov/pubmed/36325323
http://dx.doi.org/10.3389/fimmu.2022.1011185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621319/
https://www.ncbi.nlm.nih.gov/pubmed/36325323
http://dx.doi.org/10.3389/fimmu.2022.1011185

Ejemplares similares